Clinical Trial Update: Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE) [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 trial CONSOLIDATE evaluating enfortumab vedotin with radiation therapy for locally advanced bladder cancer; recruitment is currently open.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Padcev (enfortumab vedotin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Bladder Cancer | Phase 1, Phase 2 | Status: RECRUITING